Imcyse reports successful first-in-human Phase 1b study in type 1 diabetes with IMCY-0098 – Andrew Lloyd & Associates

Imcyse reports successful first-in-human Phase 1b study in type 1 diabetes with IMCY-0098

Liège, Belgium, August 27, 2019 – Imcyse,a clinical-stage company developing active and specific immunotherapeutics for the treatment and prevention of … Continue reading Imcyse reports successful first-in-human Phase 1b study in type 1 diabetes with IMCY-0098